Febuxostat (Feburic tablet) in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems-Reference-Cited by-同舟云学术

Febuxostat (Feburic tablet) in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems

Published:2013-10-28 Issue:6 Volume:36 Page:433-440
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Hiramitsu Shinya,Ishiguro Yoshiaki,Matsuyama Hiroyuki,Yamada Kenji,Kato Kazuo,Noba Manji,Uemura Akihisa,Matsubara Yoshirou,Yoshida Satoshi,Kani Atsushi,Tokuda Mamoru,Kato Hisashi,Hasegawa Kazuo,Uchiyama Tatsushi,Matsubara Shiro,Mori Kazuma,Kimura Hisashi,Shino Kenji,Kato Yasuchika,Ishii Junichi

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10641963.2013.846358

Reference34 articles.

1. Gout. Epidemiology of gout

2. Management of Acute and Chronic Gouty Arthritis

3. Clinical manifestations of hyperuricemia and gout

4. Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular safety risks associated with gout treatments;Expert Opinion on Drug Safety;2020-08-12

2. Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat;Pharmaceuticals;2018-05-25

3. Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis;Annals of Medicine;2016-11-12

4. Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study;PLOS ONE;2015-12-18

5. Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study;The Journal of Rheumatology;2015-06-15